Conférences en 2009

2009 - 2008 - 2007 - 2006 - 2005 - 2004 et avant

1. The dependance of RBE on design of the commercial brachytherapy seeds calculated using Monte Carlo methods. B Reniers, H Afsharpour, F Verhaegen and L Beaulieu. Oral presentation, Second European Workshop on  Monte Carlo treatment planning, Cardiff, UK October 19-21 (2009).
2. Toward a more accurate dose calculation technique using a semiautomatic organ contouring in Monte Carlo post-implant assessment of breast LDR brachytherapy. H Afsharpour, JP Pignol, B Keller, JF Carrier, B Reniers, F Verhaegen and L Beaulieu. Oral presentation, Second European Workshop on  Monte Carlo treatment planning, Cardiff, UK October 19-21 (2009).
3. Comparison of clinical outcome in intermediate risk prostate cancer patient treated with permanent seeds implant alone or external beam radiotherapy and HDR boost. É Vigneault, AG Martin, N Laflamme and L Beaulieu. Oral presentation, 2009 CARO Annual Scientific Meeting, Sept 30-Oct 3 Québec, Québec [Abstract]. Radiother Oncol 92(suppl. 2), p.S2 (2009)
4. Inclusion of SPECT images in the inverse planning of lung cancer. J St-Hilaire, A Dagnault, F Beaulieu, D Tremblay, L Beaulieu.  Poster presentation, 55th CARO Annual Scientific Meeting, Sept 30-Oct 3 Québec, Québec [Abstract].  Radiother Oncol 92(suppl. 2), p. S58 (2009)
5. Prostate edema after fiducial marker implantation. T Derashodian, É Vignault, F Meyer, L Beaulieu, S Aubin and AG Martin. Poster presentation, 55th CARO Annual Scientific Meeting, Sept 30-Oct 3 Québec, Québec [Abstract].  Radiother Oncol 92(suppl. 2), p. S62 (2009)

6. In vivo dosimetry for HDR brachytherapy using a scintillating fiber dosimeter. F Therriault-Proulx, M Villeneuve, A Martin, L Gingras, S Beddar, L Beaulieu.  Moderated poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2427-2428 (2009)

7. An algorithm for metal streaking reduction in cone beam CT.  M Bazalova, G Landry, L Beaulieu, B Reniers, F Verhaegen.  Poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2437 (2009)

8. An automatic method for reduction of metal artifacts caused by metallic implants. C Xu, L Beaulieu, D Laurendeau, F Verhaegen.  Poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2444-2445 (2009)

9. Importance of contamination signal removal on HDR brachytherapy in vivo dosimetry when using a scintillating fiber dosimeter.  F Therriault-Proulx, M Guillot, L Gingras, L Beaulieu, S Beddar.  Poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2536-2537 (2009)

10. Perfusion-based plan optimization for lung cancer using an anatomy-based aperture inverse planning system.  J St-Hilaire, F Beaulieu, A Dagnault, D Tremblay, L Beaulieu.  Poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2555 (2009)

11. Toward a more accurate dose calculation technique using a semiautomatic organ contouring in Monte Carlo post-implant assessment of breast LDR brachytherapy.  H Afsharpour, J Pignol, B Keller, J Carrier, B Reniers, F Verhaegen, L Beaulieu. Poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2615 (2009)

12. Tissue inhomogeneities in Monte Carlo treatment planning for proton therapy.  L Beaulieu, M Bazalova, C Furstoss, F Verhaegen.  Poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2616 (2009)

13. Toward a true real-time in vivo dosimetry system using plastic scintillators.  L Archambault, T Briere, F Peonisch, L Beaulieu, S Beddar.  Moderator poster presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2709 (2009)

14. Dose comparison study of a 2D scintillating fiber dosimeter array prototype with ionization chamber and film measurements.  M Guillot, L Gingras, L Beaulieu.  Oral presentation, 51st AAPM Annual Meeting, July 25-30 Anaheim, California, USA [Abstract].  Med Phys 36(6), p. 2809 (2009)

15. Optimizing number and position of catheters within Inverse Planning Simulated Annealing (IPSA) for prostate and breast high dose rate brachytherapy. G Ayotte, M D'Amours, S Aubin, É Lessard, J Pouliot, L. Beaulieu.  Young Investigator Symposium, 55th Annual Meeting of the COMP, July 21-24 Victoria, BC.  Med Phys 36(9), p. 4315 (2009)
16. In-vivo dose measurements for high-dose-rate brachytherapy using a new scintillation fiber dosimetry system: a prostate phantom study.  F Therriault-Prouls, M Villeneuve, AG Martin, L Gingras, S Beddar and L Beaulieu.  Oral presentation, 30th Annual Meeting of the American Brachytherapy Society, May 31 - June 2 Toronto, Ontario [Abstract]. Brachytherapy 8, p. 115 (2009)
17. Monte Carlo inverse planning in high-dose-rate brachytherapy: The impact of source energy spectra on heterogeneities and boundaries. M D'Amours, D Liu, É Lessard, J Pouliot, F Verhaegen and L Beaulieu.  Poster presentation, 30th Annual Meeting of the American Brachytherapy Society, May 31 - June 2 Toronto, Ontario [Abstract].  Brachytherapy 8, p. 145-6 (2009)
18. On the impacts of uncertainty of tissue chemical composition on dose distribution for breast low-dose-rate brachytherapy.  H Afsharpour, B Keller, JP Pignol, JF Carrier, B Reniers, F Verhaegen and L Beaulieu. Poster presentation, 30th Annual Meeting of the American Brachytherapy Society, May 31 - June 2 Toronto, Ontario [Abstract].  Brachytherapy 8, p. 146 (2009)
19. Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate ¹²⁵I implant: A prospective comparative dosimetric and toxicity analysis. M Gaudet, É Vigneault, S Aubin, N Varfalvy, F Harel, L Beaulieu and AG Martin.  Poster presentation, 30th Annual Meeting of the American Brachytherapy Society, May 31 - June 2 Toronto, Ontario [Abstract].  Brachytherapy 8, p. 177-8 (2009)
20. An algorithm for efficient metal artifact reductions in permanent seed implants. L Beaulieu, C Xu, D Laurendeau, F Verhaegen. Oral presentation, GEC / ESTRO / ISIORT Europe Conference, May 13-16 Porto, Portugal. Radiother Oncol 91(suppl 1), p. S13-S14 (2009) Gagnant du prix Nucletron Most Innovative Abstract.
21. Scintillating fiber dosimeter for in vivo dose measurements in HDR brachytherapy. F Therriault-Proulx, M Villeneuve, AG Martin, L Gingras, S Beddar, L Beaulieu.  Oral presentation, GEC / ESTRO / ISIORT Europe Conference, May 13-16 Porto, Portugal. Radiother Oncol 91(suppl 1), p. S14 (2009)
22. The role of Monte Carlo simulation in brachytherapy with low-energy sources. F Verhaegen, B Reniers, C Furstoss, D Liu, E Poon, M Bazalova, M D'Amours, H Afsharpour, JP Pignol, J Carrier, L Beaulieu.  Oral presentation, GEC / ESTRO / ISIORT Europe Conference, May 13-16 Porto, Portugal. Radiother Oncol 91(suppl 1), p. S14 (2009)
23. Comparison of HDR brachytherapy sources in Monte Carlo inverse planning.  M. D'Amours, D Liu, E Lessard, J Pouliot, F Verhaegen, L Beaulieu.  F Lacroix, M Guillot, L Archambault, L Gingras, S Beddar, L Beaulieu. Oral presentation, GEC / ESTRO / ISIORT Europe Conference, May 13-16 Porto, Portugal. Radiother Oncol 91(suppl 1), p. S15 (2009)
24. HDR Brachytherapy boost for localized prostate cancer: Biochemical:Pathology disease free survival and toxicity report. AG Martin, E Vigneault, F Bachand, F Harel, L Beaulieu. Lavallee, L Gingras, S Aubin, C Cote, M Chretien, L Beaulieu. Oral presentation, GEC / ESTRO / ISIORT Europe Conference, May 13-16 Porto, Portugal. Radiother Oncol 91(suppl 1), p. S19-S20 (2009)
25. Does dose escalation to a dominant intraprostatic lesion in a permanent implant increase prostate dose parameters? M Gaudet, E Vigneault, S Aubin, N Varfalvy, F Harel, L Beaulieu, AG Martin. M Guillot, F Lacroix, F Thériault, L Beaulieu, L Gingras. Poster presentation, GEC / ESTRO / ISIORT Europe Conference, May 13-16 Porto, Portugal. Radiother Oncol 91(suppl 1), p. S35 (2009) Gagnant du prix de la meilleure présentation par affiche.